Bio-Based Synthesised and Characterized Monodispersed Curcuma longa Silver Nanoparticles Induces Targeted Anticancer Activity in Breast Cancer Cells
Eram Sheikh2★, M. L. B. Bhatt3, Madhu Tripathi2★ Corresponding author
- 1Department of Zoology, University of Lucknow.
- 2Department of Radiotherapy, KGMU, Lucknow, Uttar Pradesh, University of Lucknow, India.
CORRESPONDENCE
Eram Sheikh
Department of Radiotherapy, KGMU, Lucknow, Uttar Pradesh, University of Lucknow, India.
Received: 20-02-2018; Revised: 11-04-2018.
Volume 14, Issue 57s · pp. S340–S345 · PUBLISHED 10 September 2018 · DOI: 10.4103/pm.pm_71_18
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Among the various metal nanoparticles, plant extract‑based silver nanoparticles are gradually getting preference because the bioreduction potential of plant extracts is much faster for silver ions. The silver nanoparticles have the bactericidal activity and have shown to possess anticancer potential for developing effective and safe novel therapeutic agents. Objectives: The objective of the study was to synthesize Curcuma longa silver nanoparticles for the induction of anticancer activity in breast cancer cell. Materials and Methods: The 20 ml and 10 ml of C. longa stock extract were mixed with 10 ml and 10 µl of AgNO3 solution (A) 1 mM and (B) 1M, respectively; reduction process initiates the formation of nanoparticles as detected by color change of AgNO3 from brown to dark brown; thereafter, characterization done by ultraviolet–visible spectrophotometer, Scanning electron microscope, and transmission electron microscopy. Results: The synthesized and characterized C. longa silver nanoparticles induce targeted anticancer activity in breast cancer cells.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sheikh, E., Bhatt, M. L. B., & Tripathi, M. (2018). Bio-Based Synthesised and Characterized Monodispersed Curcuma longa Silver Nanoparticles Induces Targeted Anticancer Activity in Breast Cancer Cells. Pharmacognosy Magazine, 14(57s), S340–S345. https://doi.org/10.4103/pm.pm_71_18